Marchesini Group and AST ink partnership to strengthen aseptic production capacity and expand global market presence: Bologna, Italy Thursday, December 11, 2025, 18:00 Hrs [IST] M ...
NHSA of China adds generic lecanemab in its commercial insurance innovative drug list to treat early Alzheimer’s disease: Tokyo Thursday, December 11, 2025, 16:00 Hrs [IST] Toky ...
TempraMed signs agreement with Maccabi Healthcare Services to distribute vacuum insulator devices VIVI Cap and VIVI EPI: Vancouver, British Columbia Thursday, December 11, 2025, 1 ...
Senores Pharma bags Pharmaceutical Excellence Award at Hurun Stars of Gujarat 2025: Our Bureau, Bengaluru Thursday, December 11, 2025, 17:30 Hrs [IST] Senores Pharmaceuticals is i ...
Sun Pharma concludes National B-school Competition SUN PRISM 2025: Our Bureau, Mumbai Thursday, December 11, 2025, 16:30 Hrs [IST] Sun Pharmaceutical Industries Limited, India’s ...
IIT Bombay's TIH-IoT all set to host ATMAN 3.0 for early-stage healthtech startups: Our Bureau, Mumbai Thursday, December 11, 2025, 14:30 Hrs [IST] The Technology Innovation Hub f ...
Quanterix-Lucent & Emocog enter exclusive Korea distribution agreement for Simoa platform for blood-based Alzheimer’s diagnostics: Seoul, Republic of Korea Thursday, December 11 ...
Oral semaglutide for weight loss could be a game-changer for obesity care in India: Our Bureau, Mumbai Thursday, December 11, 2025, 15:30 Hrs [IST] New findings presented at Obesi ...
Maarga Mind Care expand to Gurgaon, targets 25 mental health hospitals across India by 2030: Our Bureau, Bengaluru Thursday, December 11, 2025, 14:15 Hrs [IST] Maarga Mind Care, a ...
Antimalarial product development partnership, MMV joins iiCON consortium: Liverpool, UK Thursday, December 11, 2025, 15:00 Hrs [IST] The antimalarial product development partnersh ...
Polpharma Biologics and Libbs Farmacêutica ink licensing agreement for biosimilar for autoimmune diseases in Brazilian market: Switzerland Thursday, December 11, 2025, 11:00 Hrs ...
Arrowhead Pharma doses first subjects in phase 1/2a study of ARO-MAPT to treat Alzheimer’s disease and other tauopathies: Pasadena, California Thursday, December 11, 2025, 12:00 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results